- Home
- BGLC vs KAPA Comparison
BGLC vs KAPA Comparison
Compare BGLC & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- KAPA
- Stock Information
- Founded
- BGLC 2017
- KAPA 2013
- Country
- BGLC Malaysia
- KAPA United States
- Employees
- BGLC N/A
- KAPA N/A
- Industry
- BGLC Medical Specialities
- KAPA
- Sector
- BGLC Health Care
- KAPA
- Exchange
- BGLC Nasdaq
- KAPA NYSE
- Market Cap
- BGLC 10.7M
- KAPA 10.8M
- IPO Year
- BGLC N/A
- KAPA 2024
- Fundamental
- Price
- BGLC $5.14
- KAPA $1.10
- Analyst Decision
- BGLC
- KAPA Strong Buy
- Analyst Count
- BGLC 0
- KAPA 3
- Target Price
- BGLC N/A
- KAPA $8.33
- AVG Volume (30 Days)
- BGLC 3.1M
- KAPA 13.4M
- Earning Date
- BGLC 08-13-2025
- KAPA 08-23-2025
- Dividend Yield
- BGLC N/A
- KAPA N/A
- EPS Growth
- BGLC N/A
- KAPA N/A
- EPS
- BGLC N/A
- KAPA N/A
- Revenue
- BGLC $9,265,870.00
- KAPA N/A
- Revenue This Year
- BGLC N/A
- KAPA N/A
- Revenue Next Year
- BGLC N/A
- KAPA N/A
- P/E Ratio
- BGLC N/A
- KAPA N/A
- Revenue Growth
- BGLC N/A
- KAPA N/A
- 52 Week Low
- BGLC $2.01
- KAPA $0.40
- 52 Week High
- BGLC $15.60
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- BGLC 55.54
- KAPA N/A
- Support Level
- BGLC $3.57
- KAPA N/A
- Resistance Level
- BGLC $7.05
- KAPA N/A
- Average True Range (ATR)
- BGLC 1.44
- KAPA 0.00
- MACD
- BGLC -0.04
- KAPA 0.00
- Stochastic Oscillator
- BGLC 25.00
- KAPA 0.00
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.